Catalyst Pharmaceutical Partners Aktie
17,82
EUR
-0,15
EUR
-0,81
%
20,92
USD
-0,09
USD
-0,40
%
Werbung
Catalyst Pharmaceutical Partners Aktie Analyse
21.09.18 | Catalyst Pharmaceutical Partners Overweight | Cantor Fitzgerald | |
30.09.14 | Catalyst Pharmaceutical Partners Buy | ROTH Capital Partners, LLC | |
14.11.12 | Catalyst Pharmaceutical Partners buy | ROTH Capital Partners, LLC | |
29.11.07 | Catalyst Pharmaceutical Partners market outperform | Rodman & Renshaw |
Werbung
Werbung